These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31252285)

  • 1. Discovery of carbazole derivatives as novel allosteric MEK inhibitors by pharmacophore modeling and virtual screening.
    Xi D; Niu Y; Li H; Noha SM; Temml V; Schuster D; Wang C; Xu F; Xu P
    Eur J Med Chem; 2019 Sep; 178():802-817. PubMed ID: 31252285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of novel
    Chen H; Qiao C; Miao TT; Li AL; Wang WY; Gu W
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1544-1561. PubMed ID: 31448648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and evaluation of acridine derivatives as multi-target Src and MEK kinase inhibitors for anti-tumor treatment.
    Cui Z; Li X; Li L; Zhang B; Gao C; Chen Y; Tan C; Liu H; Xie W; Yang T; Jiang Y
    Bioorg Med Chem; 2016 Jan; 24(2):261-9. PubMed ID: 26707846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activities of 4-substituted pyrrolo[2,3-a]carbazole Pim kinase inhibitors.
    Giraud F; Akué-Gédu R; Nauton L; Candelon N; Debiton E; Théry V; Anizon F; Moreau P
    Eur J Med Chem; 2012 Oct; 56():225-36. PubMed ID: 22982527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel and selective CDK4/6 inhibitors by pharmacophore and structure-based virtual screening.
    Yuan K; Min W; Wang X; Li J; Kuang W; Zhang F; Xie S; Yang P
    Future Med Chem; 2020 Jun; 12(12):1121-1136. PubMed ID: 32400188
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and evaluation of 5-substituted 9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as check point 1 kinase inhibitors.
    Sako Y; Ichikawa S; Osada A; Matsuda A
    Bioorg Med Chem; 2010 Nov; 18(22):7878-89. PubMed ID: 20943405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacophore-based virtual screening, synthesis, biological evaluation, and molecular docking study of novel pyrrolizines bearing urea/thiourea moieties with potential cytotoxicity and CDK inhibitory activities.
    Shawky AM; Ibrahim NA; Abourehab MAS; Abdalla AN; Gouda AM
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):15-33. PubMed ID: 33103497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New potent and selective inhibitor of Pim-1/3 protein kinases sensitizes human colon carcinoma cells to doxorubicin.
    Moreau P; Dezhenkova LG; Anizon F; Nauton L; Thery V; Liang S; Kaluzhny DN; Shtil AA
    Anticancer Agents Med Chem; 2014; 14(9):1228-36. PubMed ID: 25175798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis, and Preliminary Bioactivity Evaluation of 2,7-Substituted Carbazole Derivatives as Potent Autotaxin Inhibitors and Antitumor Agents†.
    Wang W; Zhao F; Zhao Y; Pan W; Cao P; Wu L; Wang Z; Zhao X; Zhao Y; Wang H
    Anticancer Agents Med Chem; 2019; 19(2):256-264. PubMed ID: 30173652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of allosteric MEK inhibitors. Part 2: Taming the sulfamide group balances compound distribution properties.
    Hartung IV; Hammer S; Hitchcock M; Neuhaus R; Scholz A; Siemeister G; Bohlmann R; Hillig RC; Pühler F
    Bioorg Med Chem Lett; 2016 Jan; 26(1):186-93. PubMed ID: 26611920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationally designed hecogenin thiosemicarbazone analogs as novel MEK inhibitors for the control of breast malignancies.
    Elsayed HE; Ebrahim HY; Haggag EG; Kamal AM; El Sayed KA
    Bioorg Med Chem; 2017 Dec; 25(24):6297-6312. PubMed ID: 29066046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective and effective anticancer agents: Synthesis, biological evaluation and structure-activity relationships of novel carbazole derivatives.
    Huang W; Gao Z; Zhang Z; Fang W; Wang Z; Wan Z; Shi L; Wang K; Ke S
    Bioorg Chem; 2021 Aug; 113():104991. PubMed ID: 34051416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based discovery of the first allosteric inhibitors of cyclin-dependent kinase 2.
    Rastelli G; Anighoro A; Chripkova M; Carrassa L; Broggini M
    Cell Cycle; 2014; 13(14):2296-305. PubMed ID: 24911186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological activities of new checkpoint kinase 1 inhibitors structurally related to granulatimide.
    Conchon E; Anizon F; Aboab B; Prudhomme M
    J Med Chem; 2007 Sep; 50(19):4669-80. PubMed ID: 17722905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and anticancer evaluation of novel quinoline derivatives of ursolic acid with hydrazide, oxadiazole, and thiadiazole moieties as potent MEK inhibitors.
    Jin XY; Chen H; Li DD; Li AL; Wang WY; Gu W
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):955-972. PubMed ID: 31072147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel TrkA allosteric inhibitors: Structure-based virtual screening, biological evaluation and preliminary SAR studies.
    Guo J; Xiang S; Wang J; Zhou Y; Wang Z; Zhang Z; Ding K; Lu X
    Eur J Med Chem; 2022 Jan; 228():114022. PubMed ID: 34871843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of novel 1
    Liu J; Wen Y; Gao L; Gao L; He F; Zhou J; Wang J; Dai R; Chen X; Kang D; Hu L
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):72-84. PubMed ID: 31682465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel glycogen synthase kinase-3α inhibitors: Structure-based virtual screening, preliminary SAR and biological evaluation for treatment of acute myeloid leukemia.
    Wang Y; Dou X; Jiang L; Jin H; Zhang L; Zhang L; Liu Z
    Eur J Med Chem; 2019 Jun; 171():221-234. PubMed ID: 30925338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining structure-based pharmacophore modeling, virtual screening, and in silico ADMET analysis to discover novel tetrahydro-quinoline based pyruvate kinase isozyme M2 activators with antitumor activity.
    Chen C; Wang T; Wu F; Huang W; He G; Ouyang L; Xiang M; Peng C; Jiang Q
    Drug Des Devel Ther; 2014; 8():1195-210. PubMed ID: 25214764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.